We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Broadcom
AVGO
$1.83T
| $49.1M | 0.35% |
1,555,070
+10,730
| +0.7% | +$300K |
|
52
Goldman Sachs
GS
$320B
| $48.6M | 0.34% |
246,162
+39,286
| +19% | +$7.37M |
|
53
Micron Technology
MU
$1.04T
| $47M | 0.33% |
913,096
-398,182
| -30% | -$18.8M |
|
54
Lowe's Companies
LOW
$118B
| $46.9M | 0.33% |
347,140
-143,283
| -29% | -$16.4M |
|
55
Comcast
CMCSA
$80.2B
| $46.6M | 0.33% |
1,196,526
-285,674
| -19% | -$10.9M |
|
56
Adobe
ADBE
$92.8B
| $46.3M | 0.33% |
106,424
-19,191
| -15% | -$7.11M |
|
57
Pfizer
PFE
$140B
| $46M | 0.33% |
1,484,210
-63,670
| -4% | -$2.16M |
|
58
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.68B
| $45.7M | 0.32% |
35,246
-65
| -0.2% | -$86.9K |
|
59
PepsiCo
PEP
$189B
| $45M | 0.32% |
340,355
-40,068
| -11% | -$5.28M |
|
60
Fidelity National Information Services
FIS
$21.9B
| $45M | 0.32% |
335,617
-35,463
| -10% | -$4.66M |
|
61
Lam Research
LRCX
$372B
| $44.6M | 0.32% |
1,379,020
-122,940
| -8% | -$3.35M |
|
62
Bristol-Myers Squibb
BMY
$128B
| $43.2M | 0.31% |
735,216
+93,068
| +14% | +$5.57M |
|
63
ExxonMobil
XOM
$642B
| $42.7M | 0.3% |
955,132
-67,802
| -7% | -$3.04M |
|
64
Verizon
VZ
$197B
| $42.2M | 0.3% |
766,282
-401,260
| -34% | -$22.6M |
|
65
Union Pacific
UNP
$180B
| $42.1M | 0.3% |
249,096
-96,079
| -28% | -$15.4M |
|
66
Baxter International
BAX
$11.9B
| $41.8M | 0.3% |
485,878
-209,815
| -30% | -$18.3M |
|
|
MRSH
67
Marsh
MRSH
$87.5B
| $40.4M | 0.29% |
376,585
+111,131
| +42% | +$11.2M |
|
68
Boeing
BA
$169B
| $38.7M | 0.27% |
211,126
-163,184
| -44% | -$25.1M |
|
|
DCUE
69
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $38.5M | 0.27% |
379,742
-52,818
| -12% | -$5.35M |
|
70
Medtronic
MDT
$108B
| $38.3M | 0.27% |
417,769
-153,687
| -27% | -$14.7M |
|
71
American Tower
AMT
$77.7B
| $37.4M | 0.26% |
144,741
-4,141
| -3% | -$1.02M |
|
72
Masco
MAS
$16.3B
| $36.6M | 0.26% |
727,980
+126,917
| +21% | +$5.5M |
|
73
L3Harris
LHX
$56.8B
| $36.3M | 0.26% |
214,035
-54,780
| -20% | -$10.3M |
|
74
Honeywell
HON
$78B
| $36.1M | 0.26% |
265,024
-95,323
| -26% | -$12.6M |
|
75
Citigroup
C
$225B
| $36M | 0.25% |
703,969
-25,206
| -3% | -$1.2M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.